135 related articles for article (PubMed ID: 37077073)
21. Concurrent angiomyolipomas and renal cell neoplasms in patients without tuberous sclerosis: a retrospective study.
Mei M; Rosen LE; Reddy V; Cimbaluk DJ; Gattuso P
Int J Surg Pathol; 2015 Jun; 23(4):265-70. PubMed ID: 25757955
[TBL] [Abstract][Full Text] [Related]
22. [Non clear cell renal cell carcinoma. 2008 update in renal tumor pathology].
Sibony M; Vieillefond A
Ann Pathol; 2008 Oct; 28(5):381-401. PubMed ID: 19068393
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
[TBL] [Abstract][Full Text] [Related]
24. Circularity Index on Contrast-Enhanced Computed Tomography Helps Distinguish Fat-Poor Angiomyolipoma from Renal Cell Carcinoma: Retrospective Analyses of Histologically Proven 257 Small Renal Tumors Less Than 4 cm.
Kang HS; Park JJ
Korean J Radiol; 2021 May; 22(5):735-741. PubMed ID: 33660463
[TBL] [Abstract][Full Text] [Related]
25. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y
Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
[TBL] [Abstract][Full Text] [Related]
26. Renal tumors in postmortem material.
Kozłowska J; Okoń K
Pol J Pathol; 2008; 59(1):21-5. PubMed ID: 18655367
[TBL] [Abstract][Full Text] [Related]
27. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
[TBL] [Abstract][Full Text] [Related]
28. Primary collision tumors of the kidney composed of oncocytoma and papillary renal cell carcinoma: A review.
McCroskey Z; Sim SJ; Selzman AA; Ayala AG; Ro JY
Ann Diagn Pathol; 2017 Aug; 29():32-36. PubMed ID: 28807339
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms.
Jacob JM; Williamson SR; Gondim DD; Leese JA; Terry C; Grignon DJ; Boris RS
Urology; 2015 Nov; 86(5):956-61. PubMed ID: 26126697
[TBL] [Abstract][Full Text] [Related]
30. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.
Srigley JR; Delahunt B; Eble JN; Egevad L; Epstein JI; Grignon D; Hes O; Moch H; Montironi R; Tickoo SK; Zhou M; Argani P;
Am J Surg Pathol; 2013 Oct; 37(10):1469-89. PubMed ID: 24025519
[TBL] [Abstract][Full Text] [Related]
31. [The incidence of malignant transformation of renal cysts of category 1, 2, and 2F by the BOSNIAK classification into multilocular cystic renal cell carcinoma].
Darenkov SP; Proskokov AA; Agabekian AA; Trofimov IA
Urologiia; 2018 Jul; (3):111-115. PubMed ID: 30035429
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
[TBL] [Abstract][Full Text] [Related]
33. Triple synchronous neoplasms in one kidney: report of a case and review of the literature.
Jun SY; Cho KJ; Kim CS; Ayala AG; Ro JY
Ann Diagn Pathol; 2003 Dec; 7(6):374-80. PubMed ID: 15018122
[TBL] [Abstract][Full Text] [Related]
34. Carcinomas of the Renal Pelvis, Ureters, and Urinary Bladder Share a Carcinogenic Field as Revealed in Epidemiological Analysis of Tumor Registry Data.
Aragon-Ching JB; Nizam A; Henson DE
Clin Genitourin Cancer; 2019 Dec; 17(6):436-442. PubMed ID: 31445851
[TBL] [Abstract][Full Text] [Related]
35. Renal neoplasms in younger adults: analysis of 112 tumors from a single institution according to the new 2004 World Health Organization classification and 2002 American Joint Committee on Cancer Staging System.
Cao Y; Paner GP; Perry KT; Flanigan RC; Campbell SC; Picken MM
Arch Pathol Lab Med; 2005 Apr; 129(4):487-91. PubMed ID: 15794671
[TBL] [Abstract][Full Text] [Related]
36. Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients.
Giunchi F; Fiorentino M; Vagnoni V; Capizzi E; Bertolo R; Porpiglia F; Vatrano S; Tamberi S; Schiavina R; Papotti M; Bollito E
Pathology; 2016 Jan; 48(1):41-6. PubMed ID: 27020208
[TBL] [Abstract][Full Text] [Related]
37. Dia-gnostic Challenges and Extraordinary Treatment Response in Rare Malignant PEComa Tumor of the Kidney.
Huľová S; Sycova-Mila Z; Macák D; Janega P; Chovanec M; Mardiak J; Mego M
Klin Onkol; 2018; 31(6):448-452. PubMed ID: 30545225
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological characteristics and outcomes of synchronous renal cell carcinoma and urothelial carcinoma: A population-based analysis.
Wu K; Liu X; Wang Y; Wang X; Li X
Front Public Health; 2022; 10():994351. PubMed ID: 36388369
[TBL] [Abstract][Full Text] [Related]
39. [Rare renal tumors (neoplasms other than conventional renal cell carcinoma). Clinico-pathologic aspects and review of the literature].
Casetta G; De Zan A; Moiso A; Zitella A; Viberti L; Tizzani A
Minerva Urol Nefrol; 1999 Sep; 51(3):149-56. PubMed ID: 10638178
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula.
Kopp RP; Aganovic L; Palazzi KL; Cassidy FH; Sakamoto K; Derweesh IH
Can J Urol; 2013 Jun; 20(3):6790-7. PubMed ID: 23783049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
